Whitehawk Therapeutics (WHWK) Assets Average (2011 - 2026)

Whitehawk Therapeutics (WHWK) has 16 years of Assets Average data on file, last reported at $139.0 million in Q1 2026.

• Assets Average for Q1 2026 came in at $139.0 million, down 8.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $139.0 million (down 8.63% YoY), and the FY2025 annual result was $110.6 million, up 9.08% from the prior year.
• Assets Average retreated to $139.0 million in Q1 2026 per WHWK's latest filing, from $158.9 million in the prior quarter.
• Over five years, Assets Average peaked at $207.4 million in Q2 2025 and troughed at $78.0 million in Q4 2024.
• A 5-year average of $146.3 million and a median of $150.1 million in 2022 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2024: Assets Average soared 400.5% in 2022, then sank 42.66% in 2024.
• A 5-year view of Assets Average shows it stood at $189.2 million in 2022, then declined by 28.09% to $136.0 million in 2023, then plunged by 42.66% to $78.0 million in 2024, then surged by 103.73% to $158.9 million in 2025, then fell by 12.52% to $139.0 million in 2026.
• Business Quant data shows WHWK's Assets Average at $139.0 million in Q1 2026, $158.9 million in Q4 2025, and $173.9 million in Q3 2025.